Free Allergy and Immunology CME

Treatment Updates on Chronic Inflammatory Demyelinating Polyneuropathy emphasizes the use of IVIg in the treatment of Chronic Inflammatory Demyelinating Polyneuropathy.

The presentation consists of a single lecture, Treatment Updates on Chronic Inflammatory Demyelinating Polyneuropathy, with discussion by Roy L. Freeman, MD, Richard J. Barohn, MD and Kenneth C. Gorson, MD.

After viewing Treatment Updates on Chronic Inflammatory Demyelinating Polyneuropathy, you will be better able to :
• Conduct a thorough and timely evaluation and differential diagnosis of patients with chronic inflammatory demyelinating polyneuropathy.
• Devise appropriate treatment regimen for the effective management of chronic inflammatory polyneuropathy based on guidelines and clinical evidence.

Target Audiences:
This program is intended for US-based neurologists, immunologists, physician assistants, nurse practitioners, and nurses who manage, or have an interest in managing patients with immune-mediated neuropathies.

Scientia CME Immunology – Allergy CME has three selections:
• Chronic Urticaria (CU): Therapeutic Updates, Best Practices, and Barriers to Care (1 hr CME);
• Psoriasis: Best Practices, Barriers to Care, and Emerging Therapies (1 hr CME)
• Asthma and allergic asthma: personalizing treatment to the patient and therapeutic updates (1 hr CME)

Target Audience:
Physicians specializing in Allergy or Dermatology.